Scutellarin Improves Type 2 Diabetic Cardiomyopathy by Regulating Cardiomyocyte Autophagy and Apoptosis

<div>SCU reversed cardiac pathological changes and inhibited cardiomyocyte apoptosis in the T2DC model. (a) SCU reversed the pathological changes of cardiomyocytes by HE staining assay. (b) SCU inhibited the apoptosis of cardiomyocytes by TUNEL staining assay.</div>

Disease Markers

fig2

Figure 2

Figure 2: Scutellarin Improves Type 2 Diabetic Cardiomyopathy by Regulating Cardiomyocyte Autophagy and Apoptosis 